Report
Oscar Haffen Lamm ...
  • Valliant Campagne

Aelis: AEF0117 missed binary endpoints in its phase 2b for CUD

Aelis published this morning AEF0117's phase 2b topline data in CUD, where no statistically significant effects were observed across the binary endpoints, which measured the absolute reduction in cannabis consumption. While the exact data was not communicated, it was reported that in the context an
Underlying
AELIS FARMA SA

Provider
Bryan Garnier
Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

Analysts
Oscar Haffen Lamm

Valliant Campagne

Other Reports on these Companies
Other Reports from Bryan Garnier

ResearchPool Subscriptions

Get the most out of your insights

Get in touch